Please login to the form below

Not currently logged in
Email:
Password:

Suglat

This page shows the latest Suglat news and features for those working in and with pharma, biotech and healthcare.

Otsuka's Samsca heads clutch of Japanese approvals

to reach the market in Japan after Astellas' Suglat (ipragliflozin).

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics